Radboud University Nijmegen Medical Centre
The Radboud University Nijmegen Medical Centre (RUNMC) is a leading Dutch institute for medical research. The Neuropsychiatry Research Group (Department of Cognitive Neuroscience) and the Karakter Child and Adolescent Psychiatry University Centre are specialized in top-level clinical care and research in neuropsychiatric disorders such as ADHD and Autism Spectrum Disorders, Conduct Disorder and associated problems including suicidality associated with medication. The Nijmegen outpatient clinics have about 2000 new child and adolescent patients per year.
The Neuropsychiatry Research Group has been involved in many international collaborations, including multiple site international medication trials and NIH sponsored projects on the genetics of ADHD (International Multisite ADHD Genetics – IMAGE) and on gene-by environment interactions in an Autism Birth Cohort. Both Prof. Buitelaar and Dr. Glennon have been lead Principal Investigators of several large-scale national research projects, including topics as diverse as screening studies for Autism Spectrum Disorders and translational (preclinical and clinical) pharmacology in psychiatric disorders. Prof. Buitelaar is also the Principal Investigator of the Pediatric European Risperidone Study (PERS) funded by FP7, leader of workpackages in two other FP7 funded projects (STOP and ADDUCE), and Principal Investigator of the NeuroIMAGE study.